|
Mexican OTC Drugmaker Warned for GMP Documentation Laxity
Compania Internacional de Comercio (CIC), a Mexican maker of OTC topical ointments and gels, has been handed an FDA warning letter for straying from the agency’s GMP regulations, including failing to document analytical tests and GMP procedures.
This article is viewable by subscribers only. To view this article, please select an option below.
|
Subscribe
Archives